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A B S T R A C T
Objective: To assess the factors related to the presence of polycystic ovary syndrome (PCOS) 
in adolescents. 
Methods: This was a cross-sectional study, with female adolescents from 15 to 18 years old, 
divided into: group 1 (with a medical diagnosis of PCOS) and group 2 (not diagnosed with 
PCOS). The height-for-age index and the body mass index were used for classifying the 
nutritional status, and a semi-structured questionnaire was applied. The Mann-Whitney 
test, Fisher’s exact test, Spearman correlation coefficients, and logistic regression were used. 
Results: This study evaluated 485  adolescents with an average age of 16.3 ±  0.9  years old. 
The prevalence of PCOS was 6.2%. No difference was found between the groups regarding 
anthropometric parameters and period of contraceptive use; however, there were differences 
regarding the age at menarche (p < 0.004). Older age at menarche was a protection factor 
against the syndrome. 
Conclusion: An association was found between younger age at menarche and the development 
of the PCOS in adolescents.
© 2012 Elsevier Editora Ltda. 
Síndrome do ovário policístico e fatores relacionados em adolescentes 
de 15 a 18 anos
R E S U M O
Objetivo: Avaliar os fatores relacionados à presença da síndrome do ovário policístico (SOP) 
em adolescentes. 
Métodos: Estudo transversal, com adolescentes do sexo feminino de 15 a 18 anos, divididas 
em grupo 1 (com diagnóstico médico de SOP) e grupo 2 (sem diagnóstico da síndrome). 
Palavras-chave:
Síndrome do ovário policístico
Adolescente
Estado nutricional
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Utilizou-se o índice estatura para idade e índice de massa corporal para classificação 
do estado nutricional, e aplicou-se questionário semiestruturado. Foram aplicados testes de 
Mann-Whitney, Exato de Fisher, correlação de Spearman e regressão logística. 
Resultados: Foram avaliados 485 adolescentes, com idade média de 16,3 ± 0,9 anos. A prevalên-
cia de SOP foi de 6,2%. Não se encontrou diferença entre os grupos quanto aos parâmetros 
antropométricos e tempo de uso de anticoncepcionais, porém houve diferença quanto à 
idade da menarca (p < 0,004), e a mais tardia foi fator de proteção para síndrome. 
Conclusão: Verificou-se associação entre a ocorrência da menarca precoce e o desenvolvimento 
da SOP em adolescentes.
© 2012 Elsevier Editora Ltda.  
Menarca
Doenças metabólicas
Introduction
The main characteristics of adolescence, here understood 
as the period from ages 10 to 19 years, are rapid growth and 
puberty.1
Puberty is regarded as one of the first physiological 
processes of hormonal maturation and somatic growth 
that prepares the organism to procreate. The early signs of 
secondary sexual characteristics appear and develop during 
this period, and this phase extends until the morphological and 
physiological changes are similar to the adult stage.2
Polycystic ovary syndrome (PCOS) is a complex and 
heterogeneous endocrine disorder, whose prevalence in 
women ranges from 4% to 10% during the reproductive 
period, according to different diagnostic criteria.3  It may 
result in health complications, such as menstrual dysfunction, 
infertility, hirsutism, acne, and metabolic syndrome, and it is 
considered a risk factor for diabetes mellitus type 2, arterial 
hypertension, and cardiovascular diseases.4,5
PCOS is fairly common in adolescents, and it is related 
to hormonal changes and/or morphological changes in the 
ovaries, as well as to the increased levels of insulin-like growth 
factor I (IGF-I) and insulin, which are common during puberty.6
There are several systemic changes that interact during 
PCOS, among which the changes in lipid metabolism 
(dyslipidemias) are noteworthy, in addition to those related 
to insulin sensitivity. Obesity defined as excess weight and/or 
body fat is associated with women affected by PCOS.7-9
Aiming at contributing to the research of PCOS, this study 
intended to assess the factors related to the presence of PCOS 
in adolescents from 15 to 18 years old who lived in Viçosa, 
Minas Gerais. 
Methods
This was a cross-sectional and observational study with female 
adolescents in the age group of 15 to 18 years old who attended 
high school at private and public institutions in the urban area 
of the city of Viçosa, MG, Brazil.
The sample size was calculated through the software Epi 
Info version 6.04, based on a formula specific for cross-sectional 
studies. The population of 2,233 adolescents of the gender and 
age group required by the study, living in the urban area of 
Viçosa was considered,10 with prevalence of 8%,4 acceptable 
variability of 3%,4,5 and confidence level of 99%, totaling 
437 adolescents. 
The adolescents were selected through intentional 
sampling, by convenience, and only those who had their 
menarche at least a year before were included in the study, 
resulting in a more homogeneous group.11
Weight and height were measured using the techniques 
proposed by the World Health Organization (WHO).12 Weight 
was obtained with an electronic digital scale with maximum 
capacity of 150 kg and sensitivity of 50 g, and height was obtained 
using a portable stadiometer with a maximum length of 2.13 m 
and resolution of 0.1 cm; this measurement was performed 
twice, using the average value of both measurements. Should 
the difference between the measurements exceed 0.5 cm, new 
measurements were performed. 
To evaluate the nutritional status, the height-for-age and 
body mass index (BMI)-for-age indices were used, classified 
according to the z-scores and pursuant to the WHO reference 
parameters for gender and age.13 Adolescents with overweight 
and obesity (≥ z-score +1) were classified as excess weight.
A semi-structured questionnaire, including personal data, 
type of school (public or private), date of birth, age at menarche, 
medical diagnosis of PCOS, regular use of contraceptives and 
duration of use, diagnosis of chronic non-communicable 
diseases (CNCDs), pregnancy, and smoking. 
The adolescents were grouped into group 1 (G1): with 
medical diagnosis of PCOS, and group 2 (G2): not diagnosed 
with PCOS.
Data was processed using the Excel software and analyzed 
through the Statistical Package for Social Sciences (SPSS), 
version 13.0  for Windows, and STATA, version 11.0. The 
Kolmogorov-Smirnov test for normality was used and, based 
on the result obtained, the Mann-Whitney test and Spearman’s 
correlation coefficients were used. Fisher’s exact test was used 
to verify the association between the variables analyzed. The 
level of rejection of the null hypothesis established was lower 
than 5% (p < 0.05).
Simple logistic regression was used to evaluate the 
association between PCOS (dependent variable) and the risk 
factors evaluated in this study (independent variables). 
The project was approved in November 10, 2009 (Of. Ref. 
No. 084/2009) by the Human Research Ethics Committee of 
the Universidade Federal de Viçosa. Participants older than 
18 years old or their guardians signed an informed consent.
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Results
In the present study, 485 adolescents with average age of 
16.3 ± 0.9 years old were included. The prevalence of PCOS 
found was 6.2% (n = 30).
No difference was found between the groups (p > 0.05) when 
comparing the anthropometric parameters and the period of 
contraceptive use. However, differences were found between 
the study groups regarding age at menarche (p <  0.004) 
(Table 1), and also an inverse correlation was found between 
weight and BMI values and age at menarche (r = −0.150; 
p = 0.001; r = −0.195; p < 0.001, respectively).
Figure 1 shows the adolescents’ nutritional status; G1 
presented a higher prevalence of short stature and overweight, 
but there was no difference between the groups (p < 0.05).
From the total sample, 10.3% (n = 50) of the adolescents 
used contraceptives on a regular basis; 78% of which (n = 39) 
belonged to G2. Regarding health condition and smoking 
habits, 2.7% (n =  13) had CNCDs, and 1.9% (n =  9) were 
smokers.
In the simple logistic regression analyses, the older 
age at menarche was a protection factor against PCOS. In 
this study, there was no association between BMI, height, 
duration of contraceptive use, and presence of CNCDs with 
PCOS (Table 2). 
Discussion
The hormonal changes and/or morphological changes in the 
ovaries appear to begin in childhood. The increase in levels 
of IGF-I and insulin during puberty may be related to the 
increased prevalence of PCOS in adolescence.14
The prevalences showed by population studies range 
from about 5% to 10% of women of reproductive age,15 a 
range which encompasses the 6.2% found in this study. 
Bridges et al.,16 when analyzing the growth of the ovaries 
and the prevalence of polycystic ovary in 358 girls in a 
pediatric endocrinology outpatient clinic of a hospital in 
the city of Middletown, in the United States, found a 6% 
prevalence of PCOS at 6 years of age and 26% at 15 years 
of age. Teixeira et al.,17  when studying 140  pre- and 
post-pubertal healthy girls between 2 and 18 incomplete 
years of age in an endocrinology outpatient clinic in Rio de 
Janeiro, found a 4% positive result in pre-pubertal and 11% 
in post-pubertal girls.
Bouzas18 warned that, unlike what happens in childhood, 
it is unusual in Brazil to bring teenagers to health services, 
even though sexuality, contraceptive methods, and body 
image are issues that concern them. Puberty is a phase 
in which hormonal changes occur with respect to insulin 
(relative insensitivity to insulin with compensatory hyper-
in sulinemia), gonadotropins, androgens, and estrogens, 
and the diagnosis of PCOS is a challenge, which may lead 
to the underestimation of prevalence of the disease in this 
population group.
Obesity and insulin-resistance are generally associated to 
PCOS. In a study with 49 women with PCOS, aged from 18 to 
45 years, divided according to their BMI, Kuba et al.19 found an 
association between obesity and higher prevalence of insulin 
resistance and diabetes mellitus. Martins et al.,20 studying 
60 women from 18 to 35 years presenting PCOS, revealed a 
higher cardiovascular risk in those who presented insulin 
resistance. 
Obesity and insulin resistance are more and more 
present in the adolescent population,21 and may persist 
into adulthood, triggering deleterious health effects. Thus, 
it is important to monitor this population, considering 
Independent variables OR 95% CI p
Age at menarche (years) 0.63 0.47-0.85 0.003
Body mass index (kg/m2) 0.99 0.91-1.08 0.86
Height (cm) 0.99 0.94-1.06 0.94
Period of contraceptive use (months) 1.03 0.96-1.10 0.37
Presence of CNCD 1.26 0.16-10.1 0.82
CI, confidence interval; CNCD, chronic non-communicable 
diseases; OR, odds ratio.
Table 2 – Simple logistic regression models for 
polycystic ovary syndrome in adolescents aged between 
15 and 18 years (Viçosa, Minas Gerais, Brazil, 2010).
Variables Group 1 Group 2 p
 Median (Min-Max) Median (Min-Max)  
Weight (kg) 54.7 (40.5-78.3) 56.9 (38.0-71.8) 0.89
Height (cm) 162.4 (147.3-172.9) 161.0 (147.1-175.5) 0.82
BMI (kg/m2) 20.2 (16.7-27.6) 20.4 (16.3-27.1) 0.95
Age at menarche (years) 12.0 (9.0-14.0) 12.0 (9.0-16.0) 0.004
Period of contraceptive use (months) 12.0 (1-36) 7.0 (1.0-36.0) 0.429
BMI, body mass index; G1, adolescents diagnosed with polycystic ovary syndrome; G2, adolescents not diagnosed with polycystic ovary 
syndrome. 
Mann-Whitney test.
Table 1 – Anthropometric parameters, age at menarche, and use of contraceptives – G1 and G2 adolescents. Viçosa, 
Minas Gerais, Brazil. 2010.
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the adoption of healthy habits, aiming at maintaining the 
appropriate weight and decreasing risk factors not only for 
PCOS, but also for cardiovascular diseases and metabolic 
changes.
Therefore, data on prevalence of PCOS provides knowledge 
about the distribution of the health problem in this population 
and draws attention to the investigation of its causes. It is a 
rational basis for helping with the choice of interventions to 
be implemented. They also draw the attention of healthcare 
professionals, responsible for quality care, mainly as to 
the measures to prevent such diseases in this population 
group to avoid non-reversible aggravations, as in the case of 
cardiovascular diseases.
For that purpose, it is highlighted that the treatment of 
PCOS is not limited to the approach to reproductive effects 
such as infertility, anovulation, and hirsutism, but it is also 
directed to the promotion of cardiovascular health. In this 
regard, non-pharmacological measures are being highlighted, 
especially nutritional counseling and regular practice of 
physical activities. Despite the fact that the long-term 
treatment strategies – which are more effective for PCOS 
– are not fully known, it appears that lifestyle changes, 
together with dietary changes, regular practice of physical 
activities, and weight loss, in addition to smoking cessation, 
stress management, and moderate alcohol consumption, are 
essential.22,23
In the 70’s, the “critical weight hypothesis” was postulated 
in relation to the occurrence of the first menstruation, 
based on population studies, which suggest that a weight 
of approximately 48 kg was necessary for the occurrence of 
menarche. Thereafter, this hypothesis was modified based on 
the body composition, proposing that, for the occurrence of 
menarche, it would be required that at least 17% of the total 
body weight was composed of fat at age 13 years, and that at 
least 22% body fat would be necessary for the maintenance of 
menstrual cycles at age 16 years.24
In the present study, there was no association between the 
BMI and the presence of PCOS, unlike other studies,3,18,25 which 
indicate that obese adolescents usually have higher chances to 
develop PCOS. Such result may be supported by the fact that 
the majority of adolescents in the present study had normal 
weight when classified by BMI/age, given that there was no 
difference between the groups. 
With respect to age at menarche and excess adiposity, an 
inverse correlation between weight and BMI values and age 
at menarche was observed, showing that overweight may 
be related to the occurrence of early menarche. Fonseca, 
Sichieri, and Veiga,26 when assessing 208 adolescents in 
Niterói, Brazil in the age group of 15 to 17 years old, found 
that the average age at menarche is 11 years and 5 months 
for overweight girls and 12 years and 4 months for girls with 
normal weight (p = 0.002). Accordingly, Vieira, et al.,27 when 
analyzing adolescents of Viçosa with normal weight and high 
body fat percentage (% BF), found that the average age at 
menarche was lower in those with excess adiposity (p < 0.002), 
evidencing that early menarche is usually associated with 
excessive body fat. 
The prevalence of nutritional disorders is highlighted in 
this study, and despite the lack of difference between the 
groups, there were a great number of adolescents with low 
weight, short stature, or excess weight, factors that may cause 
damages to the health of this population.
The increase in intra-abdominal adipose tissue, in 
the concentration of free testosterone, and in the insulin 
resistance in obese women occurs due to early menarche, 
which occurs earlier in obese women than in those with 
normal weight, as the menstruation, as previously reported, 
is probably initiated when the body reaches a certain body 
fat percentage.28
Huber-Buchholz, Carey, and Norman29 emphasized in their 
study that the body fat redistribution appears to be even more 
important than its loss, as the decrease in abdominal obesity 
is followed by an improvement in insulin sensitivity, resulting 
in a positive impact on the restoration of ovarian function, 
and they also presented results that confirmed the association 
between PCOS and excess weight.
Hoffman and Ehrmann,30 when analyzing the cardio-
metabolic characteristics associated with PCOS, drew attention 
to the late metabolic changes in the syndrome, mainly in 
adolescence, by affirming that, although there is a lack of data 
in relation to the rates of cardiovascular events and mortality 
in these patients, a higher prevalence of cardiovascular risk 
factors has been well documented. In accordance with this 
study, Giordano3 emphasized the favorable or determining 
conditions for cardiovascular diseases and diabetes in 
adolescents with PCOS, such as the presence of insulin 
resistance, excess weight, and increased blood pressure. Even 
though the present study did not find any association between 
PCOS and CNCDs, it cannot be affirmed that the syndrome is 
not related to these changes.
The clinical signs of PCOS differ and have several 
phenotypes, reflecting the varying degrees of metabolic 
dysfunction. History of low birth weight and early menarche 
confer increased risks that may lead to PCOS, which symptoms 
usually initiate during the period close to menarche. It may 
also begin after puberty, as a result of environmental modifiers, 
such as weight gain and sedentary lifestyle.31,32
The signs and symptoms of PCOS usually arise during 
peripubertal years with premature pubarche (PP) (appearance 
of pubic hair or jaws in girls before 8 years old with no other 
signs of puberty). Adolescents with medical history of PP have 
high risk to develop a complete phenotype of PCOS, including 
ovarian hyperandrogenism and chronic anovulation.33 
In the study by Teixeira et al.,17 conducted with 140 pre- 
and post-pubertal healthy girls between 2 and 18 incomplete 
years of age, most of those with polycystic ovaries had not 
menstruated yet, and two patients with history of menarche 
presented regular menstrual cycles and normal ovarian 
volumes, which shows the inconsistency of the results found 
in studies observed the influence of the age at menarche in 
the PCOS.
Conclusion 
It can be concluded that there is a relation between 
younger age at menarche and development of PCOS in 
adolescents. 
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It is necessary to identify and treat the factors that exert 
influence on the menarche, such as excess adiposity and 
hormonal changes, in order to mitigate the occurrence of 
PCOS and, as a result, prevent the deleterious effects of the 
disease (diabetes mellitus type 2, heart diseases, arterial 
hypertension, endometrial and ovarian cancers, infertility, 
among others). Therefore, the need to implement new 
prevention strategies at this life stage is reinforced, as they 
will reflect on adulthood.
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